Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Shareholders Have a Critical Opportunity to Send a Strong Message to Genco’s Entrenched Board Significant Investor Support Emerging to Defeat Proposals to Ratify Genco's Poison Pill and Equity...
-
Decision to Withdraw Four Nominees Reflects Diana's Commitment to Providing Shareholders an Opportunity to Affect Meaningful Change on the Genco Board Ismar and Cornell Bring a Fresh Perspective to...
-
Diana Has Consistently Offered Approximately 1.0x NAV Based on the Same Broker Valuation Source Genco Itself Used for Five Years Genco Has Now Moved the Goalposts by Adopting a New Methodology It...
-
Response Definitively Confirms the Genco Board Rejects Engagement in Meaningful Negotiations Despite Diana's Repeated Good Faith Efforts Following Third Rejection of Increasingly Compelling Offers,...
-
Details Why the Entrenched Genco Board Should Not Be Trusted to Act in Shareholders' Best Interests Contrasts Diana's Six Accomplished, Independent Nominees Against a Board That Has Spent Six Months...
-
Offer of $23.50 Per Share Represents 31% Premium to Undisturbed Share Price and 1.0x NAV — a Price Genco Shareholders Have Almost Never Seen in the Open Market Genco Board Has Refused to Engage with...